VolitionRx raises $4.1M in registered direct offering, issues 2.96M shares at $1.55 with warrants

Filed June 10, 2026 · Period ending June 7, 2026 · ~1 min read

Key Changes

• high

  Company sold 2.96 million shares at $1.55 each plus warrants to buy 1.48 million more shares, netting $4.1M after fees. Proceeds will fund research, clinical studies, commercialization, and repay some convertible notes.

  Item 1.01 verify on EDGAR →
• high

  Warrants are exercisable immediately at $1.55 per share for five years. If all warrants convert to stock, the company would receive an additional $2.3 million, but this would dilute existing shareholders by another 1.48 million shares.

  Item 1.01 verify on EDGAR →
• medium

  Warrants include ownership caps preventing any holder from exercising if it would push their stake above 4.99% (or optionally 9.99%) of outstanding shares, limiting concentration risk from warrant exercises.

  Item 1.01 verify on EDGAR →